Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Rhodamine B as an Assay Design Tool in Cell Biology
2026-09-24
Rhodamine B is more than a visible label: its value in microscopy depends on separating fluorescence readout from biological mechanism. This article connects practical dye selection to a trypsin-responsive pancreatitis nanomedicine study—and explains what that study does, and does not, establish for fluorescence assays.
-
WP1066 and the Directionality of JAK2/STAT3
2026-09-24
JAK2/STAT3 signaling can support tumor growth in one context and reparative macrophage function in another. This article examines how translational researchers can use WP1066 to probe that context dependence—while avoiding the mistaken assumption that pathway inhibition is universally beneficial.
-
Meropenem in Translational Resistance Research
2026-09-23
Meropenem is more than a broad-spectrum benchmark: its PBP-directed action can help translational teams connect susceptibility, resistance biology, and infection-model outcomes. This article outlines a research strategy for using the β-lactam antibiotic carbapenem carefully, interpreting results in the context of evolving resistance, and building reproducible experiments.
-
Lithium, Exosomal Wnt10a, and Bone Formation
2026-09-23
A 2024 ACS Applied Materials & Interfaces study shows that lithium enhances BMSC osteogenesis by promoting Rab11a-dependent trafficking and secretion of exosomal Wnt10a, which activates β-catenin signaling. The work connects lithium-driven cargo trafficking with exosome engineering and GelMA-based bone repair, while offering a mechanistic framework for studying Wnt ligand secretion in regenerative research.
-
Zwitterionic Lipids Improve mRNA Cancer Vaccines
2026-09-22
The reference study introduces membrane-destabilizing zwitterionic (MeDZ) lipids with a pH-responsive pyridine-based carboxybetaine headgroup. In mouse models, adding these lipids to established mRNA lipid nanoparticles improved antigen expression and antitumor immune activity while reducing local reactogenicity, although clinical translation and direct comparison with other PEG-lipid formulations remain unresolved.
-
Palmitic acid: Practical Protocol and QC Guide
2026-09-22
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized saturated long-chain fatty acid for solvent-based studies of lipid metabolism, insulin signaling, inflammation, and protein palmitoylation. It is not intended for direct aqueous dissolution or long-term storage as a solution, so solvent matching, controlled reconstitution, and prompt use are essential.
-
ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors
2026-09-21
The reference study identifies a drug-response vulnerability in ATRX-deficient high-grade glioma cells: increased sensitivity to multi-targeted receptor tyrosine kinase and selected PDGFR inhibitors. Its combination data further suggest that pairing RTK inhibition with temozolomide may produce greater toxicity in ATRX-mutant tumors, supporting ATRX status as a useful stratification variable in translational studies.
-
CB-5083 p97 Inhibitor Workflow Guide
2026-09-21
CB-5083 provides a practical chemical entry point for studying p97-dependent protein homeostasis disruption, stress signaling, and cancer cell apoptosis induction. This guide connects its oncology workflow to a new cGAS–p97 DNA-repair mechanism while clearly separating established evidence from assay extensions.
-
2-APB and the ER–Ca2+–Calpain Decision Point
2026-09-20
A translational framework for using 2-APB to dissect how ER calcium release, calpain activity, autophagy, and apoptosis interact under nutritional and oxidative stress.
-
AMPK–SQSTM1 Feedback in Metabolic Stress
2026-09-19
The 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress. This circuit couples lysosomal signaling to KEAP1 degradation, NRF2 activation, and antioxidant adaptation, clarifying how STK11- and KEAP1-altered cancer cells may survive nutrient and oxidative stress.
-
Streptavidin-FITC for Quantitative LNP Tracking
2026-09-18
Streptavidin-FITC can convert biotin labeling into a spatially resolved readout of nanoparticle trafficking. This article explains how to design, control, and interpret fluorescein isothiocyanate conjugated streptavidin assays in light of recent evidence that cholesterol can hinder LNP intracellular transport.
-
Palbociclib (PD0332991) Isethionate Assays
2026-09-18
A scenario-based guide to using Palbociclib (PD0332991) Isethionate, SKU A8335, in cell-cycle, viability, proliferation, and cytotoxicity workflows. It connects mechanism, formulation, protocol design, data interpretation, and practical vendor-selection criteria for more defensible laboratory results.
-
A 83-01 Workflow for Organoids and EMT Research
2026-09-17
A 83-01 enables controlled ALK-5 inhibition in reporter assays, EMT models, stem-cell systems, and emerging bovine liver organoids. This guide connects pathway-specific controls with the fatty-liver organoid workflow reported in dairy-cow research, emphasizing formulation, dose selection, assay interpretation, and troubleshooting.
-
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-09-17
A 2024 study found that Moxidectin, traditionally a macrocyclic lactone anthelmintic, enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis. Transcriptomic, genetic, biochemical, and mouse-model results support a polyene-potentiation strategy, although clinical translation remains unestablished.
-
DNA Methylation and FGFR Inhibitor Response in HNSCC
2026-09-16
Bao et al. integrated single-CpG DNA methylation, gene expression, HPV status, gene amplification, and drug-sensitivity data to investigate FGFR-pathway regulation in head and neck squamous cell carcinoma. Their findings identify methylation patterns in FGFR, FGF, and CCND1 genes as potential biomarkers for response to selective FGFR inhibitors, while emphasizing that these associations require prospective validation.